[A] the vicious rivalry among big pharmas.

大型制药公司之间的恶性竞争。

We had big pharma against us.

我们有大药业要对付我们。

One is Purdue Pharma and its owners, members of the Sackler family.

其中之一是普渡制药公司及其所有者赛克勒家族成员。

Like big pharma, though, the biotech startups have struggled to make money from antibiotics.

虽然和大型制药公司一样，生物科技创业公司也难以从抗生素中赚钱。

And I'm not saying there aren't problems with big pharma.

我不是说大型药企没有问题。

You know the pharma companies who didn't get involved nobody's criticizing them.

其它没参与研发的药企，可没有人去批评它们。

What are the Sacklers and Purdue Pharma saying about the ruling?

萨克勒家族和普渡制药公司对这一裁决有何看法?

The Sackler family, with controlling interest in Purdue Pharma, will pay part of the settlement.

控股普渡制药的萨克勒家族将支付协议的部分费用。

Oxycontin maker Purdue Pharma has filed for bankruptcy as it faces more than 2,000 lawsuits.

奥施康定(Oxycontin)制造商普渡制药(Purdue Pharma)已申请破产，该公司面临2000多起诉讼。

But that is the reality described in “Bad Pharma”, Ben Goldacre's new book.

这可不是胡话，本·戈尔达克尔的新书《医药行业的恶劣行径》便如是形容医药行业的现状。

Purdue Pharma has admitted criminal wrongdoing and will pay $8 billion in fines.

普渡制药公司承认有犯罪行为，并将支付80亿美元的罚款。

Thousands of lawsuits against Purdue Pharma, the manufacturers of OxyContin, accused it fueling an opioid epidemic.

针对奥施康定生产商普渡制药公司的数千起诉讼指控该公司加速了阿片类药物的流行。

In the settlement, Purdue Pharma is admitting that it paid doctors to write more prescriptions for Oxycontin.

协议显示普渡制药公司承认公司付钱让医生开出使用奥施康定的处方。

One of the leading manufacturers of opioid drugs Purdue Pharma has filed for bankruptcy protection chapter 11.

普渡制药公司是阿片类药物的主要制造商之一 该公司已根据破产法第11章申请破产保护。

The administration attributes some of the reasons for the phenomenon to the monopolistic power of Big Pharma.

政府将这种现象的部分原因归结于大型制药公司的垄断势力。

For years pharma firms have offered a patchwork of plans to help customers afford insulin and other drugs.

多年来，制药公司提供了各种各样的计划来帮助客户负担胰岛素和其他药物。

Prosecutors and the public have zeroed in on Purdue Pharma, which introduced the blockbuster drug OxyContin in 1996.

检察官和公众将矛头对准了普渡制药公司，该公司于1996年推出了轰动一时的药物奥施康定。

In exchange, they will pay roughly $6 billion and give up control of their company, Purdue Pharma.

作为交换，他们将支付大约60亿美元，并放弃对其公司普渡制药的控制权。

Prosecutor said Purdue Pharma had prioritized earnings over the health of patients when it encouraged doctors to prescribe Oxycontin.

检察官表示，普渡公司鼓励医生开奥施康定，将收益凌驾于病人的健康之上。

Swiss pharma giant Novartis also has a particular set of interests in the workings of the new U.S. Administration.

瑞士制药巨头“诺华”对美国新政府的运作也有着格外浓厚的兴趣。